Evaluation of non-vendor magnetic resonance imaging sequences for use in bladder cancer magnetic resonance image guided radiotherapy.

Loading...
Thumbnail Image

Embargo End Date

Authors

Chick, J
Alexander, S
Herbert, T
Huddart, R
Ingle, M
Mitchell, A
Nill, S
Oelfke, U
Dunlop, A
Hafeez, S

Document Type

Journal Article

Date

2023-07-01

Date Accepted

2023-08-11

Abstract

Hybrid systems that combine Magnetic Resonance Imaging (MRI) and linear accelerators are available clinically to guide and adapt radiotherapy. Vendor-approved MRI sequences are provided, however alternative sequences may offer advantages. The aim of this study was to develop a systematic approach for non-vendor sequence evaluation, to determine safety, accuracy and overall clinical application of two potential sequences for bladder cancer MRI guided radiotherapy. Non-vendor sequences underwent and passed clinical image qualitative review, phantom quality assurance, and radiotherapy planning assessments. Volunteer workflow tests showed the potential for one sequence to reduce workflow time by 27% compared to the standard vendor sequence.

Citation

Physics and Imaging in Radiation Oncology, 2023, 27 pp. 100481 -

Source Title

Physics and Imaging in Radiation Oncology

Publisher

ELSEVIER

ISSN

2405-6316

eISSN

2405-6316
2405-6316

Research Team

Royal Marsden Hospital - Sutton
Clinic Acad RT Huddart
Gynaecological Cancer
Radiother Phys Modelling

Notes